Linden invests in Aspirion
Overview
Deal Type |
Mergers & Acquisitions |
---|---|
Client & Transactional Partners |
Linden Capital Partners Aspirion Aquiline Capital Partners, LLC |
Our Role |
Buy-Side Advisor |
Summary
Linden Capital Partners, a Chicago-based private equity firm focused exclusively on the healthcare industry, announced that it has acquired Aspirion, a leader in technology-enabled healthcare revenue cycle management. Aspirion is a leading healthcare RCM provider across complex claims and revenue integrity, offering a broad array of technology-driven solutions for the most specialized revenue cycle challenges faced by hospital systems and healthcare providers. The company's team of healthcare, legal, and technical professionals, in conjunction with its proprietary AI-enabled software, assists hospitals and physicians in improving claims processing times and overall collections.
Linden has made a majority investment in Aspirion, a leader in tech-enabled healthcare RCM. Linden plans to support Aspirion and position the company for continued growth through strategic investments in technology and M&A. Aspirion's management team and Aquiline Capital Partners will remain investors in the Company.
KeyBanc Capital Markets is a trade name under which the corporate and investment banking products and services of KeyCorp and its subsidiaries, KeyBanc Capital Markets Inc., member FINRA/SIPC (“KBCMI”), and KeyBank National Association (“KeyBank N.A.”), are marketed. Securities products and services are offered by KeyBanc Capital Markets Inc. and by its licensed securities representatives. Banking products and services are offered by KeyBank N.A.